These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38266331)

  • 1. Vaccine nationalism is not unethical from a political ethics perspective: Learning from the global COVID-19 vaccine distribution failure.
    Shao Q
    Health Policy; 2024 Mar; 141():104996. PubMed ID: 38266331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
    Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
    Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
    [No Abstract]   [Full Text] [Related]  

  • 5. Why does the COVAX facility fail to bridge the 'immunization gap'?
    Shao Q
    J Public Health Policy; 2024 Mar; 45(1):126-136. PubMed ID: 38243069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine inequity-induced COVID-19 dilemma: Time to sober up.
    Ba Z; Qin Y; Sang Z; Wu H; Wu X; Cheng H; Ya B; Chen F
    Leg Med (Tokyo); 2024 Feb; 66():102364. PubMed ID: 38104356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022.
    Kolandai K; Milne B; von Randow M; Bullen C; Marsh S; Crump JA
    Vaccine; 2024 Feb; 42(6):1372-1382. PubMed ID: 38326132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solidarity across borders: A pragmatic need for global COVID-19 vaccine equity.
    Obinna DN
    Int J Health Plann Manage; 2022 Jan; 37(1):21-29. PubMed ID: 34585430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom.
    Vanderslott S; Emary K; Te Water Naude R; English M; Thomas T; Patrick-Smith M; Henry J; Douglas N; Moore M; Stuart A; Hodgson SH; Pollard AJ
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34666989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
    Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
    Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine equity in COVID-19: a meta-narrative review.
    Borowicz J; Zhang Z; Day G; Pinto da Costa M
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36524409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap.
    Borges LC; Zeferino de Menezes H; Crosbie E
    Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
    Aripov T; Wikler D; Asadov D; Tulekov Z; Murzabekova T; Munir KM
    BMC Med Ethics; 2022 Mar; 23(1):21. PubMed ID: 35264173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inequity in access to vaccines: the failure of the global response to the COVID-19 pandemic.
    Ugalde A; Hellmann F; Homedes N
    Salud Colect; 2022 Oct; 18():e4190. PubMed ID: 36520487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving Global Vaccine Equity: The Case for an International Pandemic Treaty.
    Jecker NS
    Yale J Biol Med; 2022 Jun; 95(2):271-280. PubMed ID: 35782474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.